• LAST PRICE
    1.3500
  • TODAY'S CHANGE (%)
    Trending Down-0.0301 (-2.1810%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    1.3800 / 1.3801
  • Day Range
    Low 1.3500
    High 1.3800
  • 52 Week Range
    Low 1.0200
    High 32.7000
  • Volume
    5,482
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.3801
TimeVolumeIMUN
11:02 ET1001.38
11:03 ET3501.36
11:05 ET42151.35
11:09 ET7851.35
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMUN
Immune Therapeutics Inc
650.6K
-0.8x
---
United StatesHSTC
HST Global Inc
629.8K
-3.0x
---
United StatesAVMR
AVRA Medical Robotics Inc
574.8K
-0.3x
---
United StatesIMUC
ImmunoCellular Therapeutics Ltd
943.5K
0.0x
---
United StatesNUGX
Nugenerex Immuno-Oncology Inc
290.9K
-0.1x
---
United StatesLAXAF
Laxai Pharma Ltd
316.9K
-0.1x
---
As of 2022-01-22

Company Information

Immune Therapeutics, Inc. is a drug development and commercialization company. The Company identifies, evaluates and seeks to acquire technologies in the medical device and drug development sectors. The Company executed two licenses, which are Cytocom, Inc. (Cytocom) and Forte Animal Health, Inc. (Forte).

Contact Information

Headquarters
2431 ALOMA AVE #124WINTER PARK, FL, United States 32792
Phone
407-680-3097
Fax
407-641-8668

Executives

Independent Chairman of the Board
Roscoe Moore
President, Chief Executive Officer, Director
Kevin Phelps

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$650.6K
Revenue (TTM)
$0.00
Shares Outstanding
481.9K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.36
EPS
$-1.59
Book Value
$-24.48
P/E Ratio
-0.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
0.2x
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.